Correlation between the structure of sarcolysine derivatives and their antitumor activity and toxicity
Laukaitis, V.A.
Voprosy Onkologii 18(9): 83-84
1972
ISSN/ISBN: 0507-3758 PMID: 4663698 Document Number: 56715
Document emailed within 1 workday
Related Documents
Laukaitis, V.A. 1972: Correlation between the structure of sarcolysine derivatives and their antitumor activity and toxicity Voprosy Onkologii 18(9): 83-84Mrozek, A.; Karolak-Wojciechowska, J.; Amiel, P.; Barbe, J. 2000: Quantitative analysis of structure-activity relationship in the acridine series. Part 2: Antitumor 9-thiadiazolo-acridine derivatives Acta Poloniae Pharmaceutica 57(6): 425-430
Zani, F.; offlotti, A.; Mazza, P. 1993: Correlation of chemical structure and mutagenic activity of derivatives of 3-amino-1,1-e-3-amino-1,2-benzoisothiazoles Bollettino Chimico Farmaceutico 132(2): 64-65
Otake, N. 1988: The structure and antitumor activity of antitumor antibiotics--recent progress Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(3): 369-379
Brzezińska, E.; Stańczak, A.; Ochocki, Z. 2003: Structure and biological activity of some 4-amino-3-cinnolinecarboxylic acid derivatives. QSAR analysis of cinnoline derivatives with antibacterial properties Acta Poloniae Pharmaceutica 60(1): 15-20
Ferrazzi, E.; Palumbo, M.; Valisena, S.; Antonello, C.; Palù, G. 1986: Antitumor activity of new anthraquinone derivatives Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(5): 330-336
Rose, W.C.; Schurig, J.E.; Huftalen, J.B.; Bradner, W.T. 1982: Antitumor activity and toxicity of cisplatin analogs Cancer Treatment Reports 66(1): 135-146
Taillandier, G.; Pera, M.H. 1990: Comparative structure-activity and structure-toxicity of a series of 2,4-oxazolidinediones Die Pharmazie 45(7): 536-537
Schwartz, P.M.; Dunigan, J.M.; Marsh, J.C.; Handschumacher, R.E. 1980: Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil Cancer Research 40(6): 1885-1889
Kato, T.; Suzumura, Y.; Takamoto, S.; Ota, K. 1987: Antitumor activity and toxicity in mice of RA-700, a cyclic hexapeptide Anticancer Research 7(3 Part B): 329-334
Kato, T.; Suzumura, Y.; Fukushima, M.; Honda, T.; Nakanishi, T.; Noguchi, T. 1988: Antitumor activity of novel ailanthone derivatives in vitro and in vivo Anticancer Research 8(4): 573-579
Mao, M.; Chen, Y.; Tian, X. 1998: Synthesis and antitumor activity of new heterocyclic 5-fluorouracil derivatives Yao Xue Xue Bao 33(5): 389-391
Morrow, M.; Wait, R.B.; Rosenthal, R.A.; Gamelli, R.L. 1987: Verapamil enhances antitumor activity without increasing myeloid toxicity Surgery 101(1): 63-68
Luo, W.; Zhao, Y.-m.; Wang, Y.-x.; Xie, S.-q.; Zhao, J.; Wang, C.-j. 2007: Synthesis and antitumor activity of benzoic nitrogen mustard derivatives Yao Xue Xue Bao 42(12): 1327-1329
Wang, B.; Pan, X.-d.; Liu, H.-y.; Yang, J.; Lü, Z.-y.; Zhao, J.-h. 2006: Synthesis and antitumor activity of nitrogen-based thiocolchicine derivatives Yao Xue Xue Bao 41(11): 1057-1063
Fukushima, K.; Toyoshima, S. 1975: Antitumor activity of amino acid derivatives in the primary screening Gan 66(1): 29-36
Pan, X-dao.; Liu, H-yan.; Sun, P-yang.; Zhu, C-gen.; Yang, J.; Yuan, K-hong.; Han, R. 2004: Synthesis and antitumor activity of 20-O-linked camptothecin ester derivatives Yao Xue Xue Bao 39(8): 591-597
Naresh, R.A.; Udupa, N.; Devi, P.U. 1996: Toxicity and antitumor activity of niosomal bleomycin in tumor bearing mice Indian Journal of Experimental Biology 34(8): 764-772
Ariyoshi, Y.; Ota, K. 1989: Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Pt: 2-2): 1379-1385
Niitani, H. 1999: Navelbine (vinorelbine): a review of its antitumor activity and toxicity in clinical studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(10): 1495-1507